Global Drug Survey

Also known as: GDS

Global anonymous survey platform with explicit psychedelic-use and microdosing self-report outputs in periodic reports.

Real-World Data Snapshot

Verified

Verification

Verified

Coverage

Global

Access Model

Registration required

Last Verified

Apr 7, 2026

Methodology

GDS gathers anonymous international self-report survey data to estimate patterns and harms; findings are observational and sample-dependent.

Digital platforms for patient self-reportingAd-hoc / irregularPatient self-report data

Primary Dataset

Source Evidence

3 sources

GDS 2020 Psychedelics Report

https://www.globaldrugsurvey.com/gds-2020-psychedelics-report/

Global Drug Survey Data Sharing Policy

https://www.globaldrugsurvey.com/about-us/data-sharing-policy/

Global Drug Survey 2021 Global Report

https://www.globaldrugsurvey.com/wp-content/uploads/2021/12/Report2021_global.pdf